This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Leucyl aminopeptidase (EC 3.4.11.1)B0TZZ0Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine.
J Proteome Res. 2011 Mar 4;10(3):954-67. doi: 10.1021/pr1009756. Epub 2011 Feb 9.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)B0TYL7Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine.
J Proteome Res. 2011 Mar 4;10(3):954-67. doi: 10.1021/pr1009756. Epub 2011 Feb 9.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa.
Proteomics. 2011 Aug;11(16):3424-9. doi: 10.1002/pmic.201000212.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q9PP04Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuni.
J Proteomics. 2014 Feb 26;98:90-8. doi: 10.1016/j.jprot.2013.12.014. Epub 2013 Dec 29.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Epoxide-Mediated Differential Packaging of Cif and other Virulence Factors into Outer Membrane Vesicles.
J Bacteriol. 2014 Aug 11. pii: JB.01760-14.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Epoxide-Mediated Differential Packaging of Cif and other Virulence Factors into Outer Membrane Vesicles.
J Bacteriol. 2014 Aug 11. pii: JB.01760-14.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)P58475Production of outer membrane vesicles by the plague pathogen Yersinia pestis.
PLoS One. 2014 Sep 8;9(9):e107002. doi: 10.1371/journal.pone.0107002. eCollection 2014.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q8ZBH3Production of outer membrane vesicles by the plague pathogen Yersinia pestis.
PLoS One. 2014 Sep 8;9(9):e107002. doi: 10.1371/journal.pone.0107002. eCollection 2014.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Quantitative proteomics unravels that the post-transcriptional regulator Crc modulates the generation of vesicles and secreted virulence determinants of Pseudomonas aeruginosa.
J Proteomics. 2015 Sep 8;127(Pt B):352-64. doi: 10.1016/j.jprot.2015.06.009. Epub 2015 Jun 21.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Quantitative proteomics unravels that the post-transcriptional regulator Crc modulates the generation of vesicles and secreted virulence determinants of Pseudomonas aeruginosa.
J Proteomics. 2015 Sep 8;127(Pt B):352-64. doi: 10.1016/j.jprot.2015.06.009. Epub 2015 Jun 21.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Tracking the Dynamic Relationship between Cellular Systems and Extracellular Subproteomes in Pseudomonas aeruginosa Biofilms.
J Proteome Res. 2015 Nov 6;14(11):4524-37. doi: 10.1021/acs.jproteome.5b00262. Epub 2015 Oct 2.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Tracking the Dynamic Relationship between Cellular Systems and Extracellular Subproteomes in Pseudomonas aeruginosa Biofilms.
J Proteome Res. 2015 Nov 6;14(11):4524-37. doi: 10.1021/acs.jproteome.5b00262. Epub 2015 Oct 2.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Tracking the Dynamic Relationship between Cellular Systems and Extracellular Subproteomes in Pseudomonas aeruginosa Biofilms.
J Proteome Res. 2015 Nov 6;14(11):4524-37. doi: 10.1021/acs.jproteome.5b00262. Epub 2015 Oct 2.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O68822Tracking the Dynamic Relationship between Cellular Systems and Extracellular Subproteomes in Pseudomonas aeruginosa Biofilms.
J Proteome Res. 2015 Nov 6;14(11):4524-37. doi: 10.1021/acs.jproteome.5b00262. Epub 2015 Oct 2.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)O32106Extracellular vesicle proteomes reflect developmental phases of Bacillus subtilis.
Clin Proteomics. 2016 Mar 9;13:6. doi: 10.1186/s12014-016-9107-z. eCollection 2016.
COG0260273 / 29 / 244
Aminopeptidase B (EC 3.4.11.23)A6D2Z2Outer membrane vesicles containing signaling molecules and active hydrolytic enzymes released by a coral pathogen Vibrio shilonii AK1.
Environ Microbiol. 2016 Apr 21. doi: 10.1111/1462-2920.13344.
COG0260273 / 29 / 244
Aminopeptidase B (EC 3.4.11.23)A6D2Z2Outer membrane vesicles containing signaling molecules and active hydrolytic enzymes released by a coral pathogen Vibrio shilonii AK1.
Environ Microbiol. 2016 Apr 21. doi: 10.1111/1462-2920.13344.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)B2FMS4Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia.
J Proteomics. 2016 May 9. pii: S1874-3919(16)30187-7. doi: 10.1016/j.jprot.2016.05.001.
COG0260273 / 29 / 244
Putative leucine aminopeptidaseB2FJ44Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia.
J Proteomics. 2016 May 9. pii: S1874-3919(16)30187-7. doi: 10.1016/j.jprot.2016.05.001.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Cytosol aminopeptidase (EC 3.4.11.1) (Aminopeptidase A/I) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)P68768Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Peptidase B (EC 3.4.11.23) (Aminopeptidase B)A0A061YLR7Antibiotics and Iron-limiting conditions and their effect on the production and composition of outer membrane vesicles secreted from clinical isolates of extraintestinal pathogenic E. coli.
Proteomics Clin Appl. 2016 Sep 26. doi: 10.1002/prca.201600091.
COG0260273 / 29 / 244
Probable cytosol aminopeptidaseQ2FZV6Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response.
Nat Commun. 2017 Sep 20;8(1):626. doi: 10.1038/s41467-017-00729-8.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q7VW48Outer Membrane Vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to Bordetella pertussis adhesion to epithelial cells.
Mol Cell Proteomics. 2017 Dec 4. pii: RA117.000045. doi: 10.1074/mcp.RA117.000045.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q7VW48Outer Membrane Vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to Bordetella pertussis adhesion to epithelial cells.
Mol Cell Proteomics. 2017 Dec 4. pii: RA117.000045. doi: 10.1074/mcp.RA117.000045.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q9PP04The bile salt sodium taurocholate induces Campylobacter jejuni outer membrane vesicle production and increases OMV-associated proteolytic activity.
Cell Microbiol. 2017 Dec 4. doi: 10.1111/cmi.12814.
COG0260273 / 29 / 244
Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase)Q5NFC1Amino Acid Deprivation and Central Carbon Metabolism Regulate the Production of Outer Membrane Vesicles and Tubes by Francisella.
Mol Microbiol. 2017 Dec 14. doi: 10.1111/mmi.13897.
COG0260273 / 29 / 244
[1]